Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Riximyo (rituximab) uses:
Riximyo is a medication given intravenously. It is administered to adults to treat non-Hodgkin's lymphoma and chronic lymphocytic leukemia. In addition, it is administered to treat the following:
| Fact Table | |
|---|---|
| Formula | C6416H9874N1688O1987S44 |
| License | FDA approved |
| Bioavailability | Not applicable (intravenous administration) |
| Legal status | Prescription only |
| Chemical Name | Rituximab |
| Elimination half-life | Approximately 18 days |
| Dosage (Strength) | 100 mg/10 mL, 500 mg/50 mL |
| Pregnancy | Consult a healthcare provider |
| Brands | Riximyo, Rituxan, MabThera |
| Protein binding | Not significantly bound to plasma proteins |
| PubChem CID | 5283560 |
| MedlinePlus | a607038 |
| ChEBI | 73252 |
| ATC code | L01XC02 |
| DrugBank | DB00073 |
| KEGG | D02995 |
| Routes of administration | Intravenous |
The appropriate Riximyo treatment regimen for you will be determined by your doctor. Riximyo will be administered via an intravenous infusion by a healthcare professional. To help manage side effects, you may also receive medications before your infusion.
You may speak with your doctor if you have any questions or concerns about the medication.
Rituximab is the active ingredient in Riximyo.
If you have any of the following, you should avoid Riximyo treatment:
Some, but not all, Riximyo side effects include the following: infections, abnormal blood cell counts, infusion-related reactions, nausea, itching, rash, hair loss, fever, chills, weakness, and headache. If you experience bothersome or persistent side effects, tell your doctor right away.
For more information about Riximyo, you can talk to your doctor.
Riximyo. European Medicines Agency; 2022.
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews